Phase 3 Trial of Stem Cell Therapy NeuroNata-R Enrolling in Korea

A Phase 3 clinical trial is recruiting adults with amyotrophic lateral sclerosis (ALS) to evaluate the safety and effectiveness of NeuroNata-R (lenzumestrocel), a stem cell therapy approved to treat ALS in South Korea. Enrollment is currently ongoing in South Korea, and patients interested in participating must be able to stay in the country for at least 14 months, Corestem, the therapy’s developer, stated in an email to ALS News Today. ALS is a progressive neurodegenerative disorder caused by the gradual loss of […]